Please assess the completion status of the following clinical trial:

Trial Title: The Effect of Dexamethasone on Rebound Pain in Patients Receiving Ilioinguinal and Iliohypogastric Nerve Block

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* ASA I-II~* Having signed a written informed consent form~* Scheduled for unilateral primary hernia repair Lichtenstein style (open surgery with insertion of mesh) under general anesthesia~Exclusion Criteria:~* Chronic opioid use (more than one month of 60 mg of oral morphine equivalents daily)~* Contraindications to peripheral nerve blocks including localized infection, coagulopathy, or allergy to local anesthetics~* Stomach ulcer~* Severe obesity (body mass index \> 35 kg/m2)~* Uncontrolled Diabetes~* Psychiatric disorders~* Systemic steroid use~* Neuropathic disorder~* Can not communicate in Turkish

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Group Dexa (Type: ACTIVE_COMPARATOR): After induction of general anesthesia, an ultrasound-guided block of the ilioinguinal and iliohypogastric nerve block will be performed using 20 ml 0.5% bupivacaine. 5 mg dexamethasone in a 50 ml syringe containing normal saline will be infused within 15 minutes. A multimodal analgesia regimen will be applied postoperatively.~The syringe will be prepared by a nurse outside the research team and the study participants, care providers, and data collectors will be blinded to the allocation throughout the study
- Group S (Type: SHAM_COMPARATOR): After induction of general anesthesia, an ultrasound-guided block of the ilioinguinal and iliohypogastric nerve block will be performed using 20 ml 0.5% bupivacaine. 50 mL normal saline in a 50 ml syringe will be infused within 15 minutes. A multimodal analgesia regimen will be applied postoperatively.~The syringe will be prepared by a nurse outside the research team and the study participants, care providers, and data collectors will be blinded to the allocation throughout the study

Based on this trial design, predict the completion outcome and termination type (if applicable).